United States, Institutional

Changechevron_right
highlight_off

Thank you for your registration

You will shortly receive an email with your unique link to our preference center.

Wellington Alternative Investments

...

Contact us

menu
search
Skip to main content

Search to find the correct information:
search
Search

Biotech

Showing of Insights Posts
nilesh-kumar1
Innovation Venture capital Biotech Private Investing Program Private investing Video
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

Private biotech innovation versus hype

Nilesh Kumar discusses the next generation of biotech disruptors in obesity, autoimmunity, and oncology, focusing on drugs that solve real-world unmet medical needs.

Continue reading

By

Nilesh Kumar, PhD

event
3 min
Video
2026-06-30
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
1349253411
Biotech Venture capital Private equity Private Investing Program Liquid alternatives & hedge funds Health care Innovation Private investments Article
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

Private biotech: Immunology and inflammation’s third wave

Our experts discuss how I&I is building on industry progress to offer new treatment solutions and interesting opportunities for private biotech investors. 

Continue reading

Multiple authors

event
5 min
Article
2025-12-01
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
97970762
Small-cap Global Industry Research Biotech Institutional Program Discover Large-cap Thematic solutions Article Equity
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

Strong fundamentals, attractive valuations: Why the time may be right for active biotech investing

From solid fundamentals to supportive macro conditions, learn why our biotech experts believe the industry may be ready to run.

Continue reading

By

Wen Shi, PhD, CFA

Mark Sevecka, PhD

event
8 min
Article
2025-10-31
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
2032712798
Private investing Venture capital Biotech Private Investing Program Private equity Private companies Article
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

Biotech IPOs in 2025: Quantity, quality, and best practices

We explore today's biotech IPO market, highlighting recent market trends, key characteristics for successful biotech IPOs, and best practices to sustain momentum as a public biotechnology company.

Continue reading

By

Nilesh Kumar, PhD

William Craig

event
4 min
Article
2025-08-31
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
543195947
Biotech Private companies Innovation Private investing Liquid alternatives & hedge funds Americas Private investments Article
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

Innovation and M&A driving biotech recovery

We are optimistic that the biotech market will continue to recover, supported by innovation, an improving macroeconomic environment, continued M&A activity, and improved fundamentals for the sector.

Continue reading

By

Irina Margine, PhD

event
10 min
Article
2025-04-30
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
1387055829
Biotech Global Industry Research Health care Equity Article
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

Novel therapies changing the course of health care

Several new drug classes represent a growing investment opportunity set that could reshape the health care sector.

Continue reading

By

Blake Tye

event
Article
2024-10-31
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
1441707651
Biotech Venture capital Private equity Private investments Private portfolio companies Late stage Liquid alternatives & hedge funds Video
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

Private investing portfolio company interview with RayzeBio CEO Ken Song

Dr. Ken Song, President and CEO of RayzeBio, discusses the company’s innovative approach to radiopharmaceuticals and highlights how Wellington’s public and private investment expertise is distinctive in the health care space.

Continue reading
event
Video
2024-09-30
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
podcasts mic stand and headphones
Private equity Private portfolio companies Equity Biotech Late stage Private company management WELLSaid Podcast No Optimizely Unique Perspectives Brand Private investments Podcast
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

Private biotech market: Innovation, valuations, and capital efficiency

Co-heads of biotech private investments I-hung Shih and Nilesh Kumar join host Thomas Mucha to explore today's private biotech market, highlighting the state of deal flow, valuations, and innovation.

Continue reading

By

Thomas Mucha

Nilesh Kumar, PhD

event
Podcast
2024-03-31
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
biotech-innovation
Biotech Private equity Fundamental equity Private companies Regulatory Private investments Article
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

Private biotech: Innovation amid disruption

We explore the state of the private biotech market, highlight key areas of innovation, and share three themes we expect to continue.

Continue reading

Multiple authors

event
Article
2024-04-03
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
healthcare 2023 outlook
Health care Biotech Innovation Brand Economic cycle Equity Global Industry Research Article Outlook
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

Health care outlook for 2023

Looking ahead to 2023, members of our health care team see meaningful innovation, supportive valuations, and a benign political and regulatory backdrop across biopharma, medical tech, and health care services sectors.

Continue reading

Multiple authors

event
Article
2023-12-31
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
10 LOAD {count} MORE

URL References

Related Insights

© Copyright 2025 Wellington Management Company LLP. All rights reserved. WELLINGTON MANAGEMENT ® is a registered service mark of Wellington Group Holdings LLP. For institutional or professional investors only.

View More

Enjoying this content?

Get similar insights delivered straight to your inbox. Simply choose what you’re interested in and we’ll bring you our best research and market perspectives.

View More
highlight_off

Thank you for joining our email preference center.

You’ll soon receive an email with a link to access and update your preferences.

Sorry, not interested

View More